1 February 2021 in Cell Death & Disease
MCPH1 is a causal gene for the neurodevelopmental disorder, human primary microcephaly (MCPH1, OMIM251200). Most pathogenic mutations are located in the N-terminal region of the gene, which encodes a BRCT domain, suggesting an important function of this domain in brain size determination. To investigate the specific function of the N-terminal BRCT domain in vivo, we generated a mouse model lacking the N’-BRCT domain of MCPH1 (referred as Mcph1-ΔBR1). These mutant mice are viable, but exhibit reduced brain size, with a thinner cortex due to a reduction of neuroprogenitor populations and premature neurogenic differentiation. Mcph1-ΔBR1 mice (both male and female) are infertile; however, almost all female mutants develop ovary tumours. Mcph1-ΔBR1 MEF cells exhibit a defect in DNA damage response and DNA repair, and show the premature chromosome condensation (PCC) phenotype, a hallmark of MCPH1 patient cells and also Mcph1 knockout cells. In comparison with Mcph1 complete knockout mice, Mcph1-ΔBR1 mice faithfully reproduce all phenotypes, indicating an essential role of the N-terminal BRCT domain for the physiological function of MCPH1 in the control of brain size and gonad development as well as in multiple cellular processes.
1 January 2026 in Ageing and Cancer Research & Treatment
O-GlcNAcylation, a dynamic and nutrient-sensitive post-translational modification, has emerged as a key regulator of aging processes. In this review, we summarize the biological basis of O-GlcNAcylation and explore its emerging roles in aging and age-related diseases. Then we focus on the molecular mechanisms of O-GlcNAcylation in the context of key hallmarks of aging, including genomic stability, epigenetic regulation, proteostasis, autophagy, nutrient metabolism, mitochondrial function, and immunity. Finally, we discuss the therapeutic potential of targeting O-GlcNAcylation to alleviate aging-related decline and treat age-associated diseases.
17 July 2023 in Thesciencebreaker
Aging is like a box full of secrets. Inside this "Pandora's box" lies a ticking time bomb of viruses, obsolete from millions of years ago, called endogenous retroviruses (ERVs). Using different aging models and technologies, researchers have proven that the reactivation of ERVs acts as both a biomarker and driver of aging, which provides potential interventions to “control the plague” of aging.